During the past decade, Celerion GB Ltd. conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Celerion GB Ltd." #1 collaborator was "Alkem Laboratories Ltd" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Celerion GB Ltd." are "Cystic Fibrosis" (1 trials) and "Healthy Male Subjects" (1 trials). Many other conditions were trialed in "Celerion GB Ltd." in a lesser frequency.

Most popular intervention types in "Celerion GB Ltd." are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "ENZ215" (1 trials), "EU Sourced Prolia" (1 trials), "FDL169" (1 trials), "FDL176" (1 trials) and "US Sourced Prolia" (1 trials). Other intervention names were less common.

The vast majority of trials in "Celerion GB Ltd." are 1 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Celerion GB Ltd.". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Celerion GB Ltd., 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Celerion GB Ltd., 2 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".